Agilon Ptb Ratio from 2010 to 2024

AGL Stock  USD 2.17  0.04  1.81%   
Agilon Health PTB Ratio yearly trend continues to be quite stable with very little volatility. PTB Ratio may rise above 8.14 this year. PTB Ratio is price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on Agilon Health's equity relative to its net asset value. View All Fundamentals
 
PTB Ratio  
First Reported
2010-12-31
Previous Quarter
7.75401321
Current Value
8.14
Quarterly Volatility
27.29431781
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Agilon Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Agilon Health's main balance sheet or income statement drivers, such as Tax Provision of 936.1 K, Interest Income of 5.6 M or Discontinued Operations of 561.5 K, as well as many indicators such as Price To Sales Ratio of 1.13, Dividend Yield of 0.0 or PTB Ratio of 8.14. Agilon financial statements analysis is a perfect complement when working with Agilon Health Valuation or Volatility modules.
  
Check out the analysis of Agilon Health Correlation against competitors.
For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.

Latest Agilon Health's Ptb Ratio Growth Pattern

Below is the plot of the Ptb Ratio of agilon health over the last few years. It is price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value. Agilon Health's PTB Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Agilon Health's overall financial position and show how it may be relating to other accounts over time.
Ptb Ratio10 Years Trend
Slightly volatile
   Ptb Ratio   
       Timeline  

Agilon Ptb Ratio Regression Statistics

Arithmetic Mean(35.51)
Coefficient Of Variation(76.87)
Mean Deviation23.22
Median(52.22)
Standard Deviation27.29
Sample Variance744.98
Range62.1104
R-Value0.79
Mean Square Error299.76
R-Squared0.63
Significance0.0004
Slope4.83
Total Sum of Squares10,430

Agilon Ptb Ratio History

2024 8.14
2023 7.75
2022 6.33
2021 9.89
2020 -42.55

About Agilon Health Financial Statements

Agilon Health investors utilize fundamental indicators, such as Ptb Ratio, to predict how Agilon Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
PTB Ratio 7.75  8.14 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether agilon health is a strong investment it is important to analyze Agilon Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Agilon Health's future performance. For an informed investment choice regarding Agilon Stock, refer to the following important reports:
Check out the analysis of Agilon Health Correlation against competitors.
For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
11.951
Earnings Share
(0.76)
Revenue Per Share
13.717
Quarterly Revenue Growth
0.276
Return On Assets
(0.1)
The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.